Hongbo Lu serves as Executive at Turning Point Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Hongbo Lu has executed 17 insider transactions totaling $27.8M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 16, 2025 involved receiving (via award) 7,819 shares valued at $0.
Hongbo Lu currently holds 54,982 shares of Turning Point Therapeutics, Inc. (TPTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hongbo Lu has been a net buyer of TPTX stock. They have purchased $27.8M and sold $0 worth of shares.
Hongbo Lu's most recent insider trade was on Dec 16, 2025, when they sold 7,819 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $19.00 |
| Discretionary |
| Sep 13, 2024 | ZBIO | $1000.0K | Purchase | 58,823 | $17.00 | Discretionary |
| Sep 13, 2024 | ZBIO | $1000.0K | Purchase | 58,823 | $17.00 | Discretionary |
| Sep 12, 2024 | TERN | $2.0M | Purchase | 190,476 | $10.50 | Discretionary |
| Sep 12, 2024 | TERN | $3.0M | Purchase | 285,714 | $10.50 | Discretionary |
| Mar 20, 2024 | ARWR | $27.5K | Purchase | 1,000 | $27.50 | Discretionary |
| Mar 19, 2024 | ARWR | $28.0K | Purchase | 1,000 | $28.00 | Discretionary |
| Mar 18, 2024 | ARWR | $27.5K | Purchase | 1,000 | $27.49 | Discretionary |
| Dec 23, 2022 | TERN | $5.5M | Purchase | 758,620 | $7.25 | Discretionary |
| Sep 7, 2022 | TERN | $2.2M | Purchase | 600,000 | $3.60 | Discretionary |
| Aug 16, 2022 | TERN | $3.6M | Purchase | 1,500,000 | $2.42 | Discretionary |
| Aug 15, 2022 | TERN | $3.6K | Purchase | 1,218 | $2.99 | Discretionary |
| Aug 12, 2022 | TERN | $3.3M | Purchase | 1,123,021 | $2.98 | Discretionary |
| Apr 22, 2019 | TPTX | $0 | Conversion | 546,820 | $N/A | Discretionary |
| Apr 22, 2019 | TPTX | $1.1M | Purchase | 60,000 | $18.00 | Discretionary |
| Apr 22, 2019 | TPTX | $0 | Conversion | 1,120,730 | $N/A | Discretionary |